Paul Tudor Jones’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Paul Tudor Jones’s Portfolio RPTP Stock Details RPTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-142,555	Closed	-$1.28M	–	1808
2016 Q3	$1.28M	Buy	142,555 +34,269	+32%	+$244K	0.03%	313
2016 Q2	$581K	Sell	108,286 -10,770	-9%	-$55.2K	0.01%	737
2016 Q1	$548K	Sell	119,056 -66,226	-36%	-$266K	0.01%	881
2015 Q4	$963K	Sell	185,282 -37,901	-17%	-$220K	0.03%	476
2015 Q3	$1.35M	Buy	223,183 +191,201	+598%	+$2.34M	0.05%	288
2015 Q2	$505K	Buy	+31,982	New	+$388K	0.01%	773
2014 Q1	–	Sell	-12,049	Closed	-$157K	–	1631
2013 Q4	$157K	Buy	+12,049	New	+$166K	0.01%	1144

Paul Tudor Jones's RPTP Position: Q4 2016 in Review

Paul Tudor Jones sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 142,555 shares — an estimated $1.28M sold.

Paul Tudor Jones first reported a position in RPTP in Q4 2013 and held it in 7 quarters. The position peaked at $1.35M in Q3 2015. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

Paul Tudor Jones reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
Paul Tudor Jones sold 142,555 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $1.28M.
Paul Tudor Jones first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q4 2013 and held it in 7 quarters.
Paul Tudor Jones's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $1.35M in Q3 2015.
0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Tudor Investment Corp's 13F filing for Q4 2016, filed 14 Feb 2017.